What's Happening?
The START Center for Cancer Research has appointed Dr. Navid Hafez as the Director of Clinical Research at its new Los Angeles site. This site is part of the START Network, the world's largest community-based network specializing in early-phase oncology
trials. Dr. Hafez brings over a decade of experience in academic and clinical research, having previously served at The Angeles Clinic and Research Institute and Yale School of Medicine. His role will involve leading early-phase research at the Los Angeles Cancer Network, which is one of the largest community-based oncology practices in the U.S. The new site aims to expand patient and physician access to advanced therapeutic options and integrate clinical research into patient care pathways.
Why It's Important?
The appointment of Dr. Hafez and the establishment of the new START Los Angeles site are significant for the advancement of oncology research and patient care. By expanding access to early-phase clinical trials, the site will provide patients with innovative treatment options and contribute to the development of new cancer therapies. This initiative is particularly important in a region with a diverse population and a high incidence of cancer diagnoses. The integration of clinical research into community-based care models can enhance treatment outcomes and improve the overall healthcare experience for patients.
What's Next?
The new START Los Angeles site will focus on conducting early-phase clinical trials and expanding access to innovative therapies. As part of the START Network, the site will collaborate with other research centers to support complex development programs. The strategic partnership with the Los Angeles Cancer Network will facilitate the integration of research and patient care, potentially leading to new treatment paradigms. The success of this initiative could encourage further expansion of community-based oncology research sites across the U.S.
